<DOC>
	<DOCNO>NCT02481141</DOCNO>
	<brief_summary>The aim pilot study assess safety preliminary efficacy 5-ALA - SFC dose 200 mg per day subject type II diabetes .</brief_summary>
	<brief_title>Pilot Study Evaluate Safety Efficacy 5-ALA-SFC Type II Diabetes</brief_title>
	<detailed_description>The primary objective ass safety 5-ALA - SFC dose 200 mg per day subject type II diabetes mellitus . Safety assess incidence adverse event clinically significant laboratory result . The secondary objective ass efficacy 5-ALA-SFC dose 200 mg per day glycemic control subject type II diabetes mellitus . Efficacy measure include fast plasma glucose level , HbA1c level , lipid profile , body weight .</detailed_description>
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<mesh_term>Aminolevulinic Acid</mesh_term>
	<criteria>1 . Males females reside Bahrain age 20 75 year old 2 . Otherwise good health opinion investigator base result medical history , physical exam laboratory assessment 3 . Diagnosed type II diabetes mellitus HbA1c &gt; 6.5 &lt; 10 % uncontrolled despite use one glycemialowering drug 4 . BMI ≤44 kg/m2 5 . Sitting BP ≤ 160/100mm Hg 6 . Sleep apnea screen negative 7 . Ophthalmological exam within normal limit judge investigator . If finding observe , must judge clinically significant . 8 . Female subject pregnant , breastfeeding , childbearing potential , agree use acceptable method birth control 1 . Liver dysfunction define liver function test &gt; 1.5 time upper limit normal 2 . Renal dysfunction define BUN and/or serum creatinine &gt; 1.5 time upper limit normal and/or eGFR &lt; 30 ml/min/1.73 m2 3 . History lifethreatening disease , cardiovascular disease , viral hepatitis , porphyria hemochromatosis 4 . Allergy ALA , SFC , component study product 5 . Use insulin management serum glucose 6 . Hypoglycemic event within previous 3 month , define serum glucose level less 70 mg/dL 7 . History sickle cell anemia disease</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>October 2015</verification_date>
</DOC>